BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10888395)

  • 1. Role of insulin resistance in heart and skeletal muscle F-18 fluorodeoxyglucose uptake in patients with non-insulin-dependent diabetes mellitus.
    Yokoyama I; Yonekura K; Ohtake T; Kawamura H; Matsumoto A; Inoue Y; Aoyagi T; Sugiura S; Omata M; Ohtomo K; Nagai R
    J Nucl Cardiol; 2000; 7(3):242-8. PubMed ID: 10888395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organ-specific insulin resistance in patients with noninsulin-dependent diabetes mellitus and hypertension.
    Yokoyama I; Ohtake T; Momomura S; Yonekura K; Yamada N; Nishikawa J; Sasaki Y; Omata M
    J Nucl Med; 1998 May; 39(5):884-9. PubMed ID: 9591594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin action on heart and skeletal muscle FDG uptake in patients with hypertriglyceridemia.
    Yokoyama I; Ohtake T; Momomura S; Yonekura K; Kobayakawa N; Aoyagi T; Sugiura S; Yamada N; Ohtomo K; Sasaki Y; Omata M; Yazaki Y
    J Nucl Med; 1999 Jul; 40(7):1116-21. PubMed ID: 10405129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM.
    Utriainen T; Takala T; Luotolahti M; Rönnemaa T; Laine H; Ruotsalainen U; Haaparanta M; Nuutila P; Yki-Järvinen H
    Diabetologia; 1998 May; 41(5):555-9. PubMed ID: 9628273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Troglitazone improves whole-body insulin resistance and skeletal muscle glucose use in type II diabetic patients.
    Yokoyama I; Yonekura K; Moritan T; Tateno M; Momose T; Ohtomo K; Inoue Y; Nagai R
    J Nucl Med; 2001 Jul; 42(7):1005-10. PubMed ID: 11438619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial glucose uptake in patients with NIDDM and stable coronary artery disease.
    Mäki M; Nuutila P; Laine H; Voipio-Pulkki LM; Haaparanta M; Solin O; Knuuti JM
    Diabetes; 1997 Sep; 46(9):1491-6. PubMed ID: 9287051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
    Vitale GD; deKemp RA; Ruddy TD; Williams K; Beanlands RS
    J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus.
    Kelley DE; Simoneau JA
    J Clin Invest; 1994 Dec; 94(6):2349-56. PubMed ID: 7989591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes.
    Bonadonna RC; Del Prato S; Saccomani MP; Bonora E; Gulli G; Ferrannini E; Bier D; Cobelli C; DeFronzo RA
    J Clin Invest; 1993 Jul; 92(1):486-94. PubMed ID: 8326013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of training status on regional disposal of circulating free fatty acids in the liver and skeletal muscle during physiological hyperinsulinemia.
    Iozzo P; Takala T; Oikonen V; Bergman J; Grönroos T; Ferrannini E; Nuutila P; Knuuti J
    Diabetes Care; 2004 Sep; 27(9):2172-7. PubMed ID: 15333480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin-dependent diabetes mellitus.
    Shamoon H; Friedman S; Canton C; Zacharowicz L; Hu M; Rossetti L
    J Clin Invest; 1994 Jun; 93(6):2562-71. PubMed ID: 8200993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin action on heart and skeletal muscle glucose uptake in essential hypertension.
    Nuutila P; Mäki M; Laine H; Knuuti MJ; Ruotsalainen U; Luotolahti M; Haaparanta M; Solin O; Jula A; Koivisto VA
    J Clin Invest; 1995 Aug; 96(2):1003-9. PubMed ID: 7635936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle.
    Kelley DE; Mintun MA; Watkins SC; Simoneau JA; Jadali F; Fredrickson A; Beattie J; Thériault R
    J Clin Invest; 1996 Jun; 97(12):2705-13. PubMed ID: 8675680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance is localized to skeletal but not heart muscle in type 1 diabetes.
    Nuutila P; Knuuti J; Ruotsalainen U; Koivisto VA; Eronen E; Teräs M; Bergman J; Haaparanta M; Voipio-Pulkki LM; Viikari J
    Am J Physiol; 1993 May; 264(5 Pt 1):E756-62. PubMed ID: 8498497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intact insulin stimulation of skeletal muscle blood flow, its heterogeneity and redistribution, but not of glucose uptake in non-insulin-dependent diabetes mellitus.
    Utriainen T; Nuutila P; Takala T; Vicini P; Ruotsalainen U; Rönnemaa T; Tolvanen T; Raitakari M; Haaparanta M; Kirvelä O; Cobelli C; Yki-Järvinen H
    J Clin Invest; 1997 Aug; 100(4):777-85. PubMed ID: 9259575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal muscle proteolysis is reduced in noninsulin-dependent diabetes mellitus and is unaltered by euglycemic hyperinsulinemia or intensive insulin therapy.
    Denne SC; Brechtel G; Johnson A; Liechty EA; Baron AD
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2371-7. PubMed ID: 7629232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance.
    Iozzo P; Chareonthaitawee P; Dutka D; Betteridge DJ; Ferrannini E; Camici PG
    Diabetes; 2002 Oct; 51(10):3020-4. PubMed ID: 12351442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM.
    Bonadonna RC; Del Prato S; Bonora E; Saccomani MP; Gulli G; Natali A; Frascerra S; Pecori N; Ferrannini E; Bier D; Cobelli C; DeFronzo RA
    Diabetes; 1996 Jul; 45(7):915-25. PubMed ID: 8666143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance.
    Fraze E; Donner CC; Swislocki AL; Chiou YA; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1985 Nov; 61(5):807-11. PubMed ID: 3900120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.
    Vaag A; Alford F; Henriksen FL; Christopher M; Beck-Nielsen H
    Diabetologia; 1995 Mar; 38(3):326-36. PubMed ID: 7758880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.